DEMURTAS, LAURA
 Distribuzione geografica
Continente #
EU - Europa 13.788
NA - Nord America 517
AS - Asia 89
SA - Sud America 1
Totale 14.395
Nazione #
IT - Italia 13.672
US - Stati Uniti d'America 511
CN - Cina 69
SE - Svezia 44
UA - Ucraina 37
GB - Regno Unito 14
SG - Singapore 12
FI - Finlandia 10
DE - Germania 8
CA - Canada 6
IN - India 4
VN - Vietnam 4
FR - Francia 3
BR - Brasile 1
Totale 14.395
Città #
Cagliari 13.618
Fairfield 76
Woodbridge 61
Chandler 48
Houston 42
Nyköping 36
Ashburn 34
Seattle 33
Ann Arbor 28
Dearborn 25
Wilmington 22
Cambridge 15
Jacksonville 13
Boardman 10
New York 10
Boston 9
Guangzhou 9
Beijing 8
Shanghai 8
Shenyang 8
Milan 7
Helsinki 5
Jiaxing 5
Nanjing 5
Toronto 5
Dong Ket 4
San Diego 4
Pune 3
Verona 3
Chicago 2
Hebei 2
London 2
Nanchang 2
Naples 2
Paris 2
Sanluri 2
Singapore 2
Wuhan 2
Zhengzhou 2
Baltimore 1
Bergamo 1
Changsha 1
Chiswick 1
Chongqing 1
Foshan 1
Hangzhou 1
Hefei 1
Hounslow 1
Islington 1
Jinan 1
Leawood 1
Lecce 1
Mountain View 1
New Orleans 1
Orange 1
Ottawa 1
Phoenix 1
Redwood City 1
Rome 1
Sassari 1
Tianjin 1
Turin 1
Washington 1
Xian 1
Totale 14.199
Nome #
Pathophysiology of cardiotoxicity induced by nonanthracycline chemotherapy 2.984
Thyroid dysfunction in disguise and treatment-related fatigue in the spotlight among metastatic colorectal cancer patients receiving regorafenib: Implications for clinical management. 2.358
Second-line angiogenesis inhibition in metastatic colorectal cancer patients: Straightforward or overcrowded? 2.034
The role of primary tumour sidedness, EGFR gene copy number and EGFR promoter methylation in RAS/BRAF wild-type colorectal cancer patients receiving irinotecan/cetuximab 1.998
The immune revolution in gastrointestinal tumours: leading the way or just following? 1.776
Angiogenesis genotyping and clinical outcome during regorafenib treatment in metastatic colorectal cancer patients 1.413
The distinctive molecular, pathological and clinical characteristics of BRAF-mutant colorectal tumors 1.211
Corrigendum: Why precision medicine should be applied across the continuum of care for metastatic colorectal cancer patients 342
Correction to: Angiogenesis Genotyping and Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib: The ALICE‑2 Study 287
REINVENT (REgorafenIb traNslational eValuation angiogENesis proTocol) 21
Fentanyl pectin nasal spray for breakthrough cancer pain treatment: a single center experience 10
Clinical Outcome of Patients With Stage IV Colorectal Cancer Receiving Combination Chemotherapy Without Surgery As Initial Treatment 2
Totale 14.436
Categoria #
all - tutte 17.222
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.222


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.595 169 116 16 45 1.458 1.006 508 73 49 40 32 83
2020/20213.868 99 158 117 1.365 777 441 216 197 73 184 147 94
2021/2022656 64 36 47 35 29 50 36 41 48 61 61 148
2022/20231.040 112 188 128 78 79 86 42 86 59 68 61 53
2023/20241.226 64 55 37 79 113 175 240 104 82 81 99 97
2024/2025110 110 0 0 0 0 0 0 0 0 0 0 0
Totale 14.436